<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01896245</url>
  </required_header>
  <id_info>
    <org_study_id>A 2013-0039</org_study_id>
    <nct_id>NCT01896245</nct_id>
  </id_info>
  <brief_title>Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)</brief_title>
  <acronym>SEVODosage</acronym>
  <official_title>Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia induction and tracheal intubation can be performed with and without neuromuscular
      blocking agents (NMBAs). Tracheal intubation can be performed with sevoflurane instead of
      NMBAs; intubating conditions are similar and the incidence of vocal cord injuries are
      similar, too.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We perform tracheal intubation with propofol, remifentanil and sevoflurane; sevoflurane is
      administered with three dosages. During tracheal intubation intubating conditions are noted.
      After surgery, all patients are examined by video laryngoscopy; moreover all patients are
      asked for hoarseness and sore throat.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of vocal cord injuries</measure>
    <time_frame>24 hours after tracheal intubation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of hoarseness</measure>
    <time_frame>24, 48, and 72 hours after tracheal intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of soar throat</measure>
    <time_frame>24, 48, and 72 hours after tracheal intubation</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Other Specified Injuries of Vocal Cord, Sequela</condition>
  <arm_group>
    <arm_group_label>sevoflurane 1,0</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 1,0: sevoflurane is administered with a concentration of 1,0 MAC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane 1,2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 1,2: sevoflurane is administered with a concentration of 1,2 MAC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane 1,4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 1,4: sevoflurane is administered with a concentration of 1,4 MAC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 1,0</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 1,0 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 1,0</arm_group_label>
    <other_name>sevo 2,0 %</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 1,2</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 1,2 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 1,2</arm_group_label>
    <other_name>sevo 2,5 %</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 1,4</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 1,4 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 1,4</arm_group_label>
    <other_name>sevo 3,0 %</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ear-nose-throat surgery

          -  orotracheal intubation for surgery of the ear

          -  ASA I-III

        Exclusion Criteria:

          -  obesity

          -  allergy against the study drugs

          -  patients with a known or suspected difficult airway

          -  diseases of the larynx
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Mencke, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. of Anesthesia and Intensive Care Medicine, University of Rostock, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care Medicine, University of Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg/Vorpommern</state>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2013</study_first_submitted>
  <study_first_submitted_qc>July 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2013</study_first_posted>
  <last_update_submitted>October 3, 2014</last_update_submitted>
  <last_update_submitted_qc>October 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Thomas Mencke</investigator_full_name>
    <investigator_title>Clinical Associate Professor Dr Thomas Mencke</investigator_title>
  </responsible_party>
  <keyword>hoarseness</keyword>
  <keyword>sore throat</keyword>
  <keyword>intubating conditions</keyword>
  <keyword>vocal cord injuries</keyword>
  <keyword>sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Muscle Hypotonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

